Penn Entertainment could be getting a buyout offer, and Wall Street analysts are debating whether it’s a good move for the company and investors.

The AI trade has lifted Nvidia stocks and other top techs in the S&P 500. But the momentum can’t last forever.

Ignore the political turmoil in Europe, says value investor David Herro, and pick up stocks like BNP Paribas and Publicis Groupe.

Walmart CEO Doug McMillon combines a tech-first strategy with a laser focus on value. Shareholders love it.

The euro-zone and the U.K. have finally begun to see improving economic prospects. That revival should be powerful enough to rise above upcoming elections and probable change

Going back to 1926, only 12 companies have lead the market in terms of market value, including AT&T, Apple, Cisco, Dupont, Exxon, GE, GM, IBM, Microsoft. Philip Morris, and Walmart.

BofA Securities analyst Justin Post points out that Tesla isn’t the only company that can benefit from the trillion-dollar opportunity self-driving taxis offer.

Raymond James analyst Srini Pajjuri increased his price target for Micron to $160 from $130.

Sales of previously owned homes in May fell 0.7% to a seasonally adjusted annual rate of 4.11 million.

Arm Holdings is likely to be at the heart of SoftBank CEO Masayoshi Son’s efforts to dominate the next wave of artificial intelligence after largely missing out on the Nvidia boom.

Barclays analyst Dan Levy expects Tesla to deliver 415,000 cars in the second quarter. That’s below the analyst consensus call.

Kevin Holt, manager of Invesco’s Comstock fund, studies companies over a 20-year cycle. Energy, healthcare stocks also make his list

CEO Bracken Darrell paid $1 million for shares of the parent of The North Face, Timberland, and Supreme.

DJT stock is down 41.6% on the month following former President Donald Trump’s historic conviction in his hush-money trial. Trump Media & Technology is the parent company of Truth Social.

The jet manufacturer is trying to buy its fuselage supplier, which was once part of the company, to improve production quality.

Sarepta says the drug was approved for ambulatory and non-ambulatory people, who are at least 4 years old, and with a confirmed mutation in the DMD gene.

Retail used unit sales at CarMax fall 3.1% from the prior year but earnings top Wall Street estimates.

TikTok releases details of plans to address national security, Eli Lilly fights more medical spas over weight-loss drug sales, and more news to start your day.